definiens: as that term is defined in the Private SecuritiesLitigation Reform Act of 1995, regarding the research, development and commercialization of pharmaceuticalproducts . Such forward - looking statements are based on - 99 -current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or changeany of them, and could cause actual outcomes and results to differ materially from current expectations . No forward - looking statement can be guaranteed . Among other risks, there can be no guarantee that the compound described inthis release will move from early stage development into full product development, that clinical trials of this compoundwill support a regulatory filing, or that the compound will receive regulatory approval or become a commerciallysuccessful product . Forward - looking statements in the press release should be evaluated together with the manyuncertainties that affect Bristol - Myers Squibb ’s business, particularly those identified in the cautionary factorsdiscussion in Bristol - Myers Squibb ’s Annual Report on Form 10 - K for the year ended December 31, 2010, itsQuarterly Reports on Form 10 - Q, and Current Reports on Form 8 - K. Bristol - Myers Squibb undertakes no obligation topublicly update any forward - looking statement, whether as a result of new information, future events, or otherwise